Actively Recruiting
University of Pittsburgh Medical Center Center for Inflammatory Bowel Disease Research Registry
Led by University of Pittsburgh · Updated on 2025-08-12
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are inviting adults with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis, who seek care at the Center for Inflammatory Bowel Disease to participate in a research registry. This observational study aims to collect medical record information to better understand the disease classification and factors influencing its natural course. The goal is to improve knowledge of IBD causes and support the development of improved and preventive treatments. Participants will provide written informed consent to allow their identifiable medical information related to IBD to be included in the Center's Research Registry. There are no treatment groups or interventions since this is an observational study. The registry facilitates retrospective research and helps identify and recruit eligible individuals for future IBD studies. During the study, participant information will be collected from medical records. Researchers will track the number of patients with IBD over 20 years to support ongoing research efforts. Participation involves allowing access to medical data without additional procedures or treatments. The study started in 2009 and is planned to continue until May 2030, with long-term follow-up based on medical record reviews.
CONDITIONS
Brief Title
Inflammatory Bowel Disease (IBD) Research Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients age 18 and above
- Seeking medical care at the Center for Inflammatory Bowel Diseases Clinic at UPMC
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 20 years
Participants with inflammatory bowel disease are observed over time to collect data about their condition.
Trial Site Locations
Total: 1 location
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
C
Claudia Ramos Rivers, MD
J
Joann Fultz
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here